Author:
Mansouri Sepideh,Teymourzadeh Azin,Farahmand Leila,Majidzadeh-A Keivan
Publisher
Springer International Publishing
Reference144 articles.
1. Ahles TA, Saykin AJ, McDonald BC, Li Y, Furstenberg CT, Hanscom BS et al (2010) Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve. J Clin Oncol 28(29):4434–4440
2. Ahles TA, Root JC, Ryan EL (2012) Cancer-and cancer treatment–associated cognitive change: an update on the state of the science. J Clin Oncol JCO 2012(2043):0116
3. Amir E, Freedman OC, Seruga B, Evans DG (2010) Assessing women at high risk of breast cancer: a review of risk assessment models. J Natl Cancer Inst 102:680–691
4. Bachman KE, Argani P, Samuels Y, Silliman N, Ptak J, Szabo S et al (2004) The PIK3CA gene is mutated with high frequency in human breast cancers. Cancer Biol Ther 3(8):772–775
5. Bakoyiannis I, Tsigka E-A, Perrea D, Pergialiotis V (2016) The impact of endocrine therapy on cognitive functions of breast cancer patients: a systematic review. Clin Drug Investig 36(2):109–118